Esophageal Cancer

28 July 2022
28 July 2022
Export Citation(s)Download PDF(s)

Esophageal Cancer

Open Access

P300/CBP-associated factor (PCAF)-mediated acetylation of Fascin at lysine 471 inhibits its actin-bundling activity and tumor metastasis in esophageal cancer

Yin-Wei Cheng,  Fa-Min Zeng,  Da-Jia Li,  Shao-Hong Wang,  Jian-Zhong He,  Zhen-Chang Guo,  Ping-Juan Nie,  Zhi-Yong Wu,  Wen-Qi Shi,  Bing Wen,  Xiu-E Xu,  Lian-Di Liao,  Zhi-Mao Li,  Jian-Yi Wu,  Jun Zhan,  Hong-Quan Zhang,  Zhi-Jie Chang,  Kai Zhang,  Li-Yan Xu,  En-Min Li, 
Open Access

MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma

Qingnan Wu,  Weimin Zhang,  Yan Wang,  Qingjie Min,  Hongyue Zhang,  Dezuo Dong,  Qimin Zhan, 
MAGE-C3 promotes cancer metastasis by inducing epithelial-mesenchymal transition and immunosuppression in esophageal squamous cell carcinoma

Our results identified that MAGE-C3 promotes tumor metastasis not only through the EMT but also by protecting tumors from immunosurveillance

Open Access

Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China

He Li,  Chao Ding,  Hongmei Zeng,  Rongshou Zheng,  Maomao Cao,  Jiansong Ren,  Jufang Shi,  Dianqin Sun,  Siyi He,  Zhixun Yang,  Yiwen Yu,  Zhe Zhang,  Xibin Sun,  Guizhou Guo,  Guohui Song,  Wenqiang Wei,  Wanqing Chen,  Jie He, 
Improved esophageal squamous cell carcinoma screening effectiveness by risk-stratified endoscopic screening: evidence from high-risk areas in China

Universal endoscopy screening is recommended for all aged 40-69 years in high-risk areas of China to control esophageal squamous cell carcinoma (ESCC). This study estimated risk-stratified endoscopic (RSES) strategies based on a previously developed ESCC prediction model in a representative Chinese population from high-risk areas. RSES would be a feasible strategy to optimize the current universal endoscopic screening strategy in high-risk areas by increasing efficiency and decreasing screening costs.

Open Access

Involvement of long non-coding RNAs in the progression of esophageal cancer

Wenhua Xue,  Yuanyuan Zheng,  Zhibo Shen,  Lifeng Li,  Zhirui Fan,  Wenbin Wang,  Zijia Zhu,  Yunkai Zhai,  Jie Zhao,  Quancheng Kan, 
Involvement of long non-coding RNAs in the progression of esophageal cancer

LncRNAs play complex and diverse roles in EC by mediating proliferation, cell cycle, apoptosis, invasion, migration, EMT, drug resistance, etc., and are closely related to EC clinicopathology and prognosis.

Open Access

BAALC-AS1/G3BP2/c-Myc feedback loop promotes cell proliferation in esophageal squamous cell carcinoma

Hongyue Zhang,  Yan Wang,  Weimin Zhang,  Qingnan Wu,  Jiawen Fan,  Qimin Zhan, 
Open Access

Phase II clinical trial using camrelizumab combined with apatinib and chemotherapy as the first-line treatment of advanced esophageal squamous cell carcinoma

Bo Zhang,  Ling Qi,  Xi Wang,  Jianping Xu,  Yun Liu,  Lan Mu,  Xingyuan Wang,  Lidan Bai,  Jing Huang, 
Open Access

Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible?

Zuyang Yuan,  Xinfeng Wang,  Xiao Geng,  Yin Li,  Juwei Mu,  Fengwei Tan,  Qi Xue,  Shugeng Gao,  Jie He, 
Liquid biopsy for esophageal cancer: Is detection of circulating cell-free DNA as a biomarker feasible?

Open Access

Clinical characteristics and survival of 5283 esophageal cancer patients: A multicenter study from eighteen hospitals across six regions in China

Yutong He,  Di Liang,  Lingbin Du,  Tiantian Guo,  Yanyu Liu,  Xibin Sun,  Ning Wang,  Min Zhang,  Kuangrong Wei,  Baoen Shan,  Wanqing Chen, 
Open Access

A new mouse esophageal cancer cell line (mEC25)-derived pre-clinical syngeneic tumor model for immunotherapy

Tuxiong Huang,  Jiao Yang,  Beilei Liu,  Li Fu, 
Open Access

Significance of long non-coding RNA AGPG for the metabolism of esophageal cancer

Rebecca Elizabeth Vargas,  Wenqi Wang, 
Open Access

Gastric cancer: current and evolving treatment landscape

Weijing Sun,  Li Yan, 
Open Access

Irinotecan plus S-1 versus S-1 in patients with previously treated recurrent or metastatic esophageal cancer (ESWN 01): a prospective randomized, multicenter, open-labeled phase 3 trial

Jing Huang,  Binghe Xu,  Ying Liu,  Junxing Huang,  Ping Lu,  Yi Ba,  Lin Wu,  Yuxian Bai,  Shu Zhang,  Jifeng Feng,  Ying Cheng,  Jie Li,  Lu Wen,  Xianglin Yuan,  Changwu Ma,  Chunhong Hu,  Qingxia Fan,  Xi Wang, 
Open Access

NS1-binding protein radiosensitizes esophageal squamous cell carcinoma by transcriptionally suppressing c-Myc

Yuwen Wang,  Jingjing Cheng,  Dan Xie,  Xiaofeng Ding,  Hailing Hou,  Xi Chen,  Puchun Er,  Furong Zhang,  Lujun Zhao,  Zhiyong Yuan,  Qingsong Pang,  Ping Wang,  Dong Qian, 
Open Access

Protein-coding genes combined with long noncoding RNA as a novel transcriptome molecular staging model to predict the survival of patients with esophageal squamous cell carcinoma

Jin-Cheng Guo,  Yang Wu,  Yang Chen,  Feng Pan,  Zhi-Yong Wu,  Jia-Sheng Zhang,  Jian-Yi Wu,  Xiu-E Xu,  Jian-Mei Zhao,  En-Min Li,  Yi Zhao,  Li-Yan Xu, 
Open Access

Impact of type 2 diabetes mellitus on short-term and long-term outcomes of patients with esophageal squamous cell cancer undergoing resection: a propensity score analysis

Wang Yao,  Yuqi Meng,  Mingjian Lu,  Wenzhe Fan,  Jinhua Huang,  Jiaping Li,  Zhihua Zhu,